Mergers & Acquisitions ·
Viatris commences $36.50 per share cash tender offer to acquire Pacira BioSciences
PCRXPacira BioSciences, Inc.
Pacira BioSciences disclosed that Viatris Inc., through its subsidiary Peach Purchaser Sub Inc., commenced a tender offer on October 30, 2026, to purchase all outstanding shares of common stock for $36.50 per share in cash. The transaction follows the Merger Agreement signed on October 8, 2026, under which Viatris will merge with and into Pacira upon consummation of the offer. Consequently, Pacira will not issue earnings results or guidance for the quarter ended September 30, 2026. Pacira BioSciences operates in the pharmaceutical industry, specializing in non-opioid pain management solutions.